Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Cross

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Surgical Oncology|January 16, 2007
Different criteria for radioactive sentinel lymph nodes has different impact on sentinel node biopsy in breast cancer patientsMichael J Cross
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2015
Analysis of VEGF-Mediated ERK5 Activity in Endothelial CellsGopika N Nithianandarajah-Jones, Michael J Cross
Journal of the American Chemical Society|September 16, 2004
Nickel-catalyzed cycloaddition of alkynes and isocyanatesHung A Duong, Michael J Cross, Janis Louie
Organic Letters|December 4, 2004
N-heterocyclic carbenes as highly efficient catalysts for the cyclotrimerization of isocyanatesHung A Duong, Michael J Cross, Janis Louie
The Journal of Biological Chemistry|October 20, 2010
Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesisKatarzyna A Uniewicz, Michael J Cross, David G Fernig
Plos One|July 14, 2010
VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-deltaKatherine Holmes, Elinor Chapman, Violaine See, et al.
Journal of Cellular Physiology|June 23, 2017
Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cellsEmma L Wilkinson, James E Sidaway, Michael J Cross
Biology Open|August 21, 2016
Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeabilityEmma L Wilkinson, James E Sidaway, Michael J Cross
Cancer Letters|July 16, 2003
Endostatin action and intracellular signaling: beta-catenin as a potential target?Johan Dixelius, Michael J Cross, Taro Matsumoto, et al.
Trends in Biochemical Sciences|September 19, 2003
VEGF-receptor signal transductionMichael J Cross, Johan Dixelius, Taro Matsumoto, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Surgical Oncology|January 16, 2007
Different criteria for radioactive sentinel lymph nodes has different impact on sentinel node biopsy in breast cancer patientsMichael J Cross
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2015
Analysis of VEGF-Mediated ERK5 Activity in Endothelial CellsGopika N Nithianandarajah-Jones, Michael J Cross
Journal of the American Chemical Society|September 16, 2004
Nickel-catalyzed cycloaddition of alkynes and isocyanatesHung A Duong, Michael J Cross, Janis Louie
Organic Letters|December 4, 2004
N-heterocyclic carbenes as highly efficient catalysts for the cyclotrimerization of isocyanatesHung A Duong, Michael J Cross, Janis Louie
The Journal of Biological Chemistry|October 20, 2010
Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesisKatarzyna A Uniewicz, Michael J Cross, David G Fernig
Plos One|July 14, 2010
VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-deltaKatherine Holmes, Elinor Chapman, Violaine See, et al.
Journal of Cellular Physiology|June 23, 2017
Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cellsEmma L Wilkinson, James E Sidaway, Michael J Cross
Biology Open|August 21, 2016
Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeabilityEmma L Wilkinson, James E Sidaway, Michael J Cross
Cancer Letters|July 16, 2003
Endostatin action and intracellular signaling: beta-catenin as a potential target?Johan Dixelius, Michael J Cross, Taro Matsumoto, et al.
Trends in Biochemical Sciences|September 19, 2003
VEGF-receptor signal transductionMichael J Cross, Johan Dixelius, Taro Matsumoto, et al.
Pageof 4